Feb 28, 2026 Inside your thyroid gland, a quiet war is being fought
Key Points Three companies to watch in the fast-growing GLP-1 space include firms with market capitalizations ranging from about $4 billion to nearly $1 trillion
What It Targets Our Epithalon + GHK-Cu combination peptides are designed to target: Cellular aging pathways, including telomere attrition, oxidative stress, and circadian disruption in midlife and beyond. Sleep quality and recovery in clients with agerelated melatonin decline, tired but wired evenings, or irregular sleepwake cycles. Visible skin agingfine lines, laxity, dullness, and textural changesthrough enhanced collagen, elastin, and dermal remodeling. Overall biological age markers in clients already investing in nutrition, exercise, stress work, and other Better Med Spa protocols (GLP1s, Tesamorelin, etc.)
This synergy causes an increase in the production and release of HGH from both sources